News archives

Home > News archives > Closing of the funding to boost R&D

Closing of the funding to boost R&D

Aug 28,2018 -- Updated 18:53 +0900 (GMT)

Sapporo, Japan, May 31, 2018 – NB Health Laboratory Co. Ltd. (Head Office: Kita-Ku, Sapporo; President: Kiyoshi Takayama, Ph.D.) today announced that NBHL has raised ¥360 million in an equity funding round through Fast Track Initiative Fund II, L.P., ANNIVERSAIRE HOLDINGS INC., SMBC Venture Capital Fund IV, L.P. and Hokkaido Seichou Kigyou Fund, L.P. The funds will be used to boost the development of NBHL GPCR mAb technology (MoGRAA® discovery engine) and strengthen the corporate system.